Microsoft and Bristol Myers Squibb join forces to advance AI lung cancer detection, aiming to improve early diagnosis and patient care.

Bristol Myers Squibb (NYSE: BMY, "BMS"), a global leader in oncology, today announced an agreement with Microsoft, a market leader in AI-powered radiology and clinical workflow technologies, aiming to ...

Bristol Myers Squibb and Microsoft have launched a digital health collaboration aimed at accelerating early detection of lung cancer using AI-driven radiology workflows. The initiative will deploy FDA ...

A team of researchers from the University of Chicago's Pritzker School of Molecular Engineering (UChicago PME) has used Quantum Machine Learning (QML) to identify cancer early.

Talk about a breath of fresh air. Researchers have developed a groundbreaking device that may one day make detecting lung cancer as easy as exhaling. “We built a screening tool that could allow ...

OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...

Lung cancer is the leading cause of cancer deaths worldwide, and early detection is key: there is a 12-fold increase in five-year survivorship between those detected at stage one versus stage four.

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...